Evidence map›Paper›PMID 38820491›Full record

Observational studyPloS one2024

Venovenous bypass in adult liver transplant recipients: A single-center observational case series.

Laurence Weinberg, Rebecca Caragata, Riley Hazard, Jarryd Ludski, Dong-Kyu Lee, Hugh Slifirski, Patrick Nugraha, Daniel Do, Wendell Zhang, Robert Nicolae and 3 more

Abstract readObservational Study
In one paragraph

Observational study in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laurence WeinbergDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.ORCID 0000-0001-7403-7680
Rebecca CaragataDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Riley HazardDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Jarryd LudskiDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Dong-Kyu LeeDepartment of Anesthesiology and Pain Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.ORCID 0000-0002-4068-2363
Hugh SlifirskiDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Patrick NugrahaDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.ORCID 0009-0009-9968-6754
Daniel DoDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Wendell ZhangDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Robert NicolaeDepartment of Anaesthesia, Austin Health, Heidelberg, Australia.
Peter KaldasDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Australia.ORCID 0000-0001-6639-8443
Michael A FinkDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Australia.
Marcos V PeriniDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Australia.ORCID 0000-0002-0165-1564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVery little information is currently available on the use and outcomes of venovenous bypass (VVB) in liver transplantation (LT) in adults in Australia. In this study, we explored the indications, intraoperative course, and postoperative outcomes of patients who underwent VVB in a high-volume LT unit.

methodsThe study was a single-center, retrospective observational case series of adult patients who underwent VVB during LT at Austin Health in Melbourne, Australia between March 2008 and March 2022. Information on baseline preoperative status and intraoperative variables, including specific VVB characteristics as well as postoperative and VVB-related complications was collected. The lengths of intensive care unit and hospital stays as well as intraoperative and in-hospital mortality were recorded.

resultsOf the 900 LTs performed at this center during the aforementioned 14-year period, 27 (3%) included a VVB procedure. VVB was performed electively in 16 of these 27 patients (59.3%) and as a rescue technique to control massive bleeding in the other 11 (40.1%). The median (interquartile range [IQR]) age of those who underwent VVB procedures was 48 (39-55) years; the median age was 56 (47-62) years in the non-VVB group (p<0.0001). The median model for end-stage liver disease (MELD) scores were similar between the two patient groups. Complete blood data was available for 622 non-VVB patients. Twenty-six VVB (96.3%) and 603 non-VVB (96.9%) patients required intraoperative blood transfusions. The median (IQR) number of units of packed red blood cells transfused was 7 (4.8-12.5) units in the VVB group compared to 3.0 units (1.0-6.0) in the non-VVB group (p<0.0001). Inpatient mortality was 18.5% and 1.1% for the VVB and non-VVB groups, respectively (p<0.0001). There were no significant differences in length of hospital stay or incidence of acute kidney injury, primary graft dysfunction, or long-term graft failure between the two groups. Patients in the VVB group experienced a higher rate of postoperative non-anastomotic biliary stricture compared to patients in the non-VVB group (33% and 7.9%, respectively; p = 0.0003).

conclusionsVVB continues to play a vital role in LT. This case series highlights the heightened risk of major complications linked to VVB. However, the global transition to selective use of VVB underscores the urgent need for collaborative multi-center studies designed to address outstanding questions and parameters related to the safe implementation of this procedure.

Indexed as

Liver TransplantationPostoperative ComplicationsAdultAustraliaFemaleHospital MortalityHumansLength of StayMaleMiddle AgedRetrospective StudiesTransplant Recipients

Identifiers

PMID38820491
PMCPMC11142538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.